Snapshot

The PMDA Conditional Early Approval pathway has been developed by the  Pharmaceuticals and Medical Devices Agency of Japan.

This pathway accelerates the regulatory review process.

It is a verification review (a recognition pathway).

Target time assessment is 9 months.